Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Sepsis Associated AKI

NCT06064487 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT06064487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06064487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Sepsis Associated AKI
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2023
Completion date
June 1, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aki - acute kidney injury